Locus Biosciences
Locus Biosciences is a precision medicine company revolutionizing the treatment of bacterial infections and addressing unmet medical needs in immunology, oncology, and CNS disorders through engineered bacteriophage products. Their core technology, the LOCUS platform, integrates advanced robotics, automated biobanking, AI-driven cocktail prediction, and synthetic biology to engineer highly effective phage cocktails. This platform allows for precise targeting of pathogenic bacteria while preserving the beneficial microbiome. Locus emphasizes its clinical success, world-class viral vector manufacturing facility for cGMP clinical trial material, and its AI-driven approach which uses machine learning for lead optimization and natural language processing on genomic data to identify optimal phage insertion sites for enhanced payload expression and stability. Their lead therapeutic, LBP-EC01, is in clinical trials for E. coli infections.
Locus Biosciences
Locus Biosciences is a precision medicine company revolutionizing the treatment of bacterial infections and addressing unmet medical needs in immunology, oncology, and CNS disorders through engineered bacteriophage products. Their core technology, the LOCUS platform, integrates advanced robotics, automated biobanking, AI-driven cocktail prediction, and synthetic biology to engineer highly effective phage cocktails. This platform allows for precise targeting of pathogenic bacteria while preserving the beneficial microbiome. Locus emphasizes its clinical success, world-class viral vector manufacturing facility for cGMP clinical trial material, and its AI-driven approach which uses machine learning for lead optimization and natural language processing on genomic data to identify optimal phage insertion sites for enhanced payload expression and stability. Their lead therapeutic, LBP-EC01, is in clinical trials for E. coli infections.